Get started
Author

Satoshi Yoshimura

ORCID: 0000-0002-4756-8790
Observed ORCID: 0000-0002-4756-8790
OpenAlex ID: A5101746995
Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod
2015 · Zi-Ye Song, Ryo Yamasaki, et al. · PLoS ONE · 77
PDF
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design
2023 · Jamie A. Jarusiewicz, Satoshi Yoshimura, et al. · ACS Medicinal Chemistry Letters · 64
PDF
A distinct GM-CSF + T helper cell subset requires T-bet to adopt a T H 1 phenotype and promote neuroinflammation
2020 · Javad Rasouli, Giacomo Casella, et al. · Science Immunology · 56
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia
2024 · Xin Huang, Yizhen Li, et al. · Cancer Cell · 39
Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia
2022 · Jianzhong Hu, Jamie Jarusiewicz, et al. · Science Translational Medicine · 32
IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production
2019 · Satoshi Yoshimura, Rodolfo Thome, et al. · The Journal of Immunology · 25
Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells
2017 · Rodolfo Thomé, Jason N. Moore, et al. · Frontiers in Immunology · 24
PDF
Direct-to-Biology Enabled Molecular Glue Discovery
2025 · Maowei Hu, Jason Ochoada, et al. · Journal of the American Chemical Society · 23
PDF
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia
2024 · Jamie A. Jarusiewicz, Satoshi Yoshimura, et al. · Journal of Medicinal Chemistry · 11
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin
2025 · Carolin S. Escherich, Zhenhua Li, et al. · Blood · 7
PDF
HLA-DPB1*0201 is associated with susceptibility to atopic myelitis in Japanese
2012 · Shinya Sato, Noriko Isobe, et al. · Journal of Neuroimmunology · 7
Development of Proteolytic Targeting Chimeras to Target Lck in T-Cell Acute Lymphoblastic Leukemia
2021 · Jianzhong Hu, Jamie Jarusiewicz, et al. · Blood · 3
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemia
2026 · Satoshi Yoshimura, Marisa Actis, et al. · Blood · 1
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemia
2025 · Jun J Yang, Gisele Nishiguchi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Transcription factor T-bet is required for pathogenicity of GM-CSF-only Th cells in experimental autoimmune encephalomyelitis
2019 · Javad Rasouli, Bogoljub Ciric, et al. · The Journal of Immunology · 1
Abstract 423: Induced proximity and proteolytic targeting of LCK as a novel therapeutic approach in T-cell leukemia
2022 · Jianzhong Hu, Jamie Jarusiewicz, et al. · Cancer Research
ThG Cells: A Distinct T Helper Cell Subset with Lineage Characteristics
2019 · Javad Rasouli, Giacomo Casella, et al. · SSRN Electronic Journal
Works count: 17
Citation count: 371
H-index: 9
I10-index: 9
Year
Topic
Type